Sun Pharmaceutical Industries Limited (BOM: 524715)
India
· Delayed Price · Currency is INR
1,761.80
-14.10 (-0.79%)
At close: Jan 21, 2025
Sun Pharmaceutical Industries Revenue
Sun Pharmaceutical Industries had revenue of 132.91B INR in the quarter ending September 30, 2024, with 9.01% growth. This brings the company's revenue in the last twelve months to 503.08B, up 8.64% year-over-year. In the fiscal year ending March 31, 2024, Sun Pharmaceutical Industries had annual revenue of 484.97B with 10.51% growth.
Revenue (ttm)
503.08B
Revenue Growth
+8.64%
P/S Ratio
n/a
Revenue / Employee
11.70M
Employees
43,000
Market Cap
4,266.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 484.97B | 46.11B | 10.51% |
Mar 31, 2023 | 438.86B | 52.31B | 13.53% |
Mar 31, 2022 | 386.54B | 51.56B | 15.39% |
Mar 31, 2021 | 334.98B | 6.61B | 2.01% |
Mar 31, 2020 | 328.38B | 37.72B | 12.98% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,398.38B |
Tata Consultancy Services | 2,520.82B |
HDFC Bank | 2,761.06B |
Bharti Airtel | 1,554.78B |
ICICI Bank | 1,638.51B |
Infosys | 1,635.60B |
State Bank of India | 3,360.28B |
ITC Limited | 751.35B |
Sun Pharmaceutical Industries News
- 5 days ago - Sun Pharma’s subsidiary Taro to acquire Antibe Therapeutics - Business Upturn
- 18 days ago - Sensex jumps over 1,400 pts, best day in nearly 2 months - The Times of India
- 19 days ago - Nifty 50 top losers today on January 2: Sun Pharmaceutical and Britannia Industries lead the decline - Business Upturn
- 19 days ago - Pharma sector stocks performance: Ipca Labs gains 1.23%, Biocon up 0.84%, Sun Pharma and Torrent Pharma slip over 1% - Business Upturn
- 25 days ago - Healthcare Sector Stock Update: Sun Pharma up 1.05%, Cipla up 1.22%, Zydus Lifesciences up 2% - Business Upturn
- 5 weeks ago - Pharma Sector Stocks: Torrent Pharma (+0.25%) rises; Glenmark (-2.29%), Aurobindo (-2.02%) decline - Business Upturn
- 5 weeks ago - Motilal Oswal’s healthcare sector picks: Sun Pharma, IPCA, Mankind, Ajanta, and Glenmark - Business Upturn
- 5 weeks ago - HSBC on Indian Pharma Sector: Strong 2025 Outlook for Cipla, Sun Pharma, and Torrent Pharma - Business Upturn